PHARMA
OrbiMed Invests US$551 Million In Asian Healthcare
The leading healthcare investment firm will use the US$551 million raised to support growth-stage product- and services-oriented companies in China and India.
Takeda And Noile-Immune Biotech Enter CAR-T Collaboration
Takeda and Noile-Immune Biotech collaborate to advance next generation CAR-T therapy effective for solid tumors.
Invitrocue & GIS Establish Joint Cancer Lab
Invitrocue and A*STAR's Genome Institute of Singapore have established a joint laboratory to develop personalized treatments for cancer patients.
Takeda And Schrödinger Team Up For Drug Discovery
Takeda Pharmaceutical Company and Schrödinger Incorporated have established a multi-target partnership for drug discovery.
Celgene Buys The Rights To BeiGene’s Checkpoint Inhibitor
BeiGene will acquire Celgene's commercial operations in China and exclusive license to Celgene's China cancer commercial portfolio.
BGI Genomics’ IPO Raises US$250 Million
BGI Genomics’ President Wang Jian says the capital raised through the initial public offering will be used to help the company dominate the genomics market.
iCarbonX Joins HealthLoop’s US$8.4 Million Series B Round
The participation of iCarbonX brings the total Series B investment in HealthLoop’s patient-engagement platform to US$8.4 million.
IHH Healthcare To Open US$200 Million Hospital In Shanghai
The 450-bed Gleneagles Shanghai Hospital is part of IHH Healthcare's planned pipeline of hospitals totalling over US$1 billion in investments.
GRAIL And Cirina Join Forces For Early Cancer Detection
GRAIL and Cirina have entered an agreement to form a global company focused on the early detection of cancer.
